How We Mark Time and How Time Marks Us
Dr. Gotlib discusses the road to approval of midostaurin for the treatment of advanced systemic mastocytosis.
A Randomized Trial in a Rare Cancer: Targeting CD30 in Cutaneous T Cell Lymphoma Yields Therapeutic Dividends
Dr. Roberts discusses a trial that looks at new therapies to be tested for the treatment of a rare cancer, cutaneous T cell lymphoma.
Download issue as PDF
Dr. Bertuch and Dr. Kurre examine the need for improvement in how acquired aplastic anemia is both diagnosed and treated in the United States.
Dr. Cuker studies the approaches of diagnosing pulmonary embolisms.
Dr. Gotlib looks at MLL3's role as a tumor suppressor.
Dr. Koury examines the implications of the identification of ERFE as an erythropoietic regulator of iron mobilization and absorption through hepcidin suppression.
Dr. Coetzer looks at the long-range molecular mechanisms underlying MYB gene expression.
Dr. Vercellotti looks into the role vascular endothelium plays as the source of factor VIII and von Willebrand factor.
Dr. Quinn explores a study on causes of alloimmunization in chronically transfused individuals with SCD.
Dr. Lollar reviews the contribution of thrombosis and bleeding to morbidity and mortality associated with myeloproliferative neoplasms.
Dr. Becker reviews a study on incorporating gene editing into certain gene therapy strategies.
Dr. Garcia reviews the recently published Pulmonary Embolism Thrombosis Study on adding intravenous tenecteplase to anticoagulation.
Dr. Joseph Mikhael discusses his approach to the evaluation of patients with an IgM monoclonal protein.
Dr. Kelley and Dr. Xu review the ways advances in DNA analysis have revolutionized our understanding of myelodysplastic syndrome (MDS).
Dr. Johnson looks at the role of FDG-PET as a guide
for consolidation radiotherapy in primary mediastinal lymphoma.
Dr. LaCasce reviews the role of brentuximab vedotin in treating patients with CD30-positive lymphoma.
Dr. Linda Burns looks forward to what the future might bring for ASH.
This fall, ASH will begin publishing a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology. ASH Clinical News will provide timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature.
September-October 2017Volume 14, Issue 5
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology